The Heart & Kidney Health Screening offers no-cost Lp(a) testing as well as screenings for other related metabolism and ...

Boston Scientific Corporation BSX recently announced favorable three-year primary endpoint data from the OPTION global ...

THEO-260 is a mechanistically novel oncolytic immunotherapy developed to tackle the stromal rich tumour microenvironment (TME) evident in ...

Researchers from the National Institutes of Health (NIH) have developed an artificial intelligence (AI) algorithm to help speed up the process of matching potential volunteers to relevant clinical ...

FDA IND approval for TB006 is a major achievement for TrueBinding and a significant potential advancement for the treatment of Parkinson’s Disease worldwide,” said Alan K. Jacobs, M.D., FAAN, Chief ...

Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical stage biopharmaceutical company focused on discovering and developi ...

While substantial progress has been made in sharing data from clinical trials, many top-selling medicines still fall short ...

In recent years, the landscape of substance abuse has shifted significantly, marked by a surge in mortality rates linked to ...

Jasper Therapeutics faces financial challenges but strong buy ratings. Read why JSPR stock is poised for growth amid risks ...

An AI tool called Muse aims to optimize clinical trial patient recruitment and accelerate the development of new therapies.